期刊文献+

恶性肿瘤贫血相关因素分析 被引量:8

Analyses of Anemia Relevent Factors in Cancer Patients
下载PDF
导出
摘要 目的:分析恶性肿瘤并发贫血的相关因素。方法:回顾性分析160例恶性肿瘤患者的临床资料,综合性分析肿瘤类型、分期、化疗、性别、年龄等因素与恶性肿瘤合并贫血的相关性。结果:160例肿瘤患者中有78例存在贫血,贫血发生率与性别、年龄无关(P>0.05),消化系统肿瘤贫血发生率高于其它部位实体瘤,肿瘤患者病理分期不同其贫血发生率也不完全相同(P<0.05),接受化疗的患者贫血发生率明显高于未接受化疗者(P<0.005)。结论:恶性肿瘤患者贫血的发生与肿瘤类型、病理分期及化疗相关。 Objective:To analyze the relevent factors of anemia in cancer patients.Method:The clinical data of 160 patients with malignant cancer were retrospectively analyzed for the possible relevent factors including tumor types,clinical stage,treatment method,gener and age.Results:Of these 160 cases,78(48.75%) had anemia.The incidence of anemia between different gender and age was not significiant(P&gt;0.05);The prevalence of anemia was higher in digestive system tumor than the other types of cancer.Different clinical stage of tumor and chemotheraphy were also found to be related with anemia(P&lt;0.05).Conclusion:The occurrence of anemia in cancer patients has significant correlation with tumor types,clinical stage and chemotherapy.
出处 《中国医药导刊》 2013年第7期1156-1157,共2页 Chinese Journal of Medicinal Guide
关键词 恶性肿瘤 贫血 分期 化疗 Milignant cancer Anemia Clinical stage Chemotheraphy
  • 相关文献

参考文献11

  • 1Link H,Schmitz S.Treatment of cancer-associated anaemia:results from a two-daycross-sectional survey in Germany [J].Onkologie,2013;36(5):266-272. 被引量:1
  • 2Caro JJ,Salas M,Ward A,et al.Anemia as an independent prognostic factorfor survival in patients with cancer:a systemic,quantitative review[J].Cancer,2001;91(12):2214-2221. 被引量:1
  • 3Schwartz RN.Anemia in patients with cancer:incidence,causes,impact,management,and use of treatment guidelines and protocols[J].Am J Health SystPharm,2007;64(Suppl 2):S5-13. 被引量:1
  • 4Grotto HZ.Anaemia of cancer:an overview of mechanisms involved in itspathogenesis[J].Med Oncol,2008;25(1):12-21. 被引量:1
  • 5冯岗,王晋,张羽,邓文斌,姚兵,李慧,杜小波,周棠馨,唐桦.恶性实体肿瘤患者贫血状况调查[J].四川医学,2009,30(2):157-159. 被引量:2
  • 6许崇安,李琳,高艳,邢丽丽,张学梅,刘殊.癌性贫血对肺癌患者生活质量及预后的影响[J].中华肿瘤防治杂志,2010,17(10):763-766. 被引量:11
  • 7田静,刘娟.癌性贫血80例临床分析[J].四川医学,2012,33(10):1748-1750. 被引量:5
  • 8Pirker R,Pirolli M,Quigley J,et al.Hemoglobin decline in cancer patientsreceiving chemotherapy without an erythropoiesis-stimulating agent[J].SupportCare Cancer,2013;21(4):987-992. 被引量:1
  • 9潘海霞,邓春美,任刚,朱学强,邓颖,杨兰,敖睿,胡洪林,刘浩.恶性肿瘤患者化疗相关贫血的治疗[J].四川医学,2011,32(10):1522-1524. 被引量:6
  • 10Harrison L,Shasha D,Shiaova L,et al.Prevalence of anemia in cancer patientsundergoing radiation therapy [J].Semin Oncol,2001;28(Suppl 8):54-59. 被引量:1

二级参考文献46

  • 1陈衍,刘文超,程婕.癌性贫血的最新临床研究进展[J].现代肿瘤医学,2008,16(11):1995-1998. 被引量:13
  • 2万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1334
  • 3许岸高,姜泊,钟旭辉,余志金,刘集鸿.广东地区近20年大肠癌临床特征的变化趋势[J].中华医学杂志,2006,86(4):272-275. 被引量:86
  • 4Heinz Ludwig. The oneologist rHuEPO and treatment outcomes [ J]. The Preclinieal Experience, 2004,9 ( suppl 5) : 48 - 54. 被引量:1
  • 5Guenter Weiss, Lawrence T Goodnough. Anemia of chronic disease[ J]. The new England Journal of Medicine,2005,10(10) : 1011 - 1023. 被引量:1
  • 6Ludwig H, Barrett-Lee PJ, Gascon P, et al. European cancer anemia survey (eECAS) defines factors surrounding anemia in thousands cancer patients [J]. Proc Am Soc Clin Oncol,2002,21 : 1546. 被引量:1
  • 7Mercadante S,Gebbia V, Marrazzo A, et al. Anaemia in cancer: pathophysiology and treatment [J]. Cancer Treat Rev, 2000,26 (4):303-311. 被引量:1
  • 8Thatcher N. Management of chemotherapy-induced anemia in solid tumors[J]. Semin Oncol,1998,25(3 Suppl 7):23-26. 被引量:1
  • 9Lugwid H, Van Bwlle S, Barrett-Lee P, et al. The European Cancer Anemia Survey (ECAS) : a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients[J]. Eurr J Cancer,2004,40(15) :2293- 2306. 被引量:1
  • 10Weiss G,Goodnough L T. Anemia of chronic disease[J]. New Engl J Med, 2005,352(10): 1011-1023. 被引量:1

共引文献37

同被引文献96

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部